Invention Grant
![Substituted imidazo[1,2-a]pyridines as PDE-10 inhibitors](/docs/US/2020-02-25/US10570156B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted imidazo[1,2-a]pyridines as PDE-10 inhibitors
-
Application No.: US15818044Application Date: 2017-11-20
-
Publication No.: US10570156B2Publication Date: 2020-02-25
- Inventor: John Emmerson Campbell , Philip Wendell Jones , Michael Charles Hewitt
- Applicant: SUNOVION PHARMACEUTICALS INC.
- Applicant Address: US MA Marlborough
- Assignee: SUNOVION PHARMACEUTICALS INC.
- Current Assignee: SUNOVION PHARMACEUTICALS INC.
- Current Assignee Address: US MA Marlborough
- Main IPC: A61K31/437
- IPC: A61K31/437 ; C07D471/04 ; C07D519/00 ; A61K45/06 ; C07D487/04 ; A61K31/4375 ; A61K31/4745 ; A61K31/4985 ; A61K31/519 ; A61K31/5383
![Substituted imidazo[1,2-a]pyridines as PDE-10 inhibitors](/abs-image/US/2020/02/25/US10570156B2/abs.jpg.150x150.jpg)
Abstract:
Provided herein are cyclic nucleotide phosphodiesterase inhibitors of Formula (I) of claim 1, and pharmaceutical compositions thereof, useful for the treatment of, for example, central nervous system and metabolic diseases and disorder.
Public/Granted literature
- US20180072759A1 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF Public/Granted day:2018-03-15
Information query
IPC分类:
